0001104659-22-032917.txt : 20220311 0001104659-22-032917.hdr.sgml : 20220311 20220311163301 ACCESSION NUMBER: 0001104659-22-032917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANDERS WARREN B CENTRAL INDEX KEY: 0000935577 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40698 FILM NUMBER: 22733598 MAIL ADDRESS: STREET 1: ONE LANDMARK SQUARE STREET 2: 22ND FLOOR CITY: STAMFORD, STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cadre Holdings, Inc. CENTRAL INDEX KEY: 0001860543 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 383873146 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 13386 INTERNATIONAL PKWY CITY: JACKSONVILLE STATE: FL ZIP: 32218 BUSINESS PHONE: (904) 741-5400 MAIL ADDRESS: STREET 1: 13386 INTERNATIONAL PKWY CITY: JACKSONVILLE STATE: FL ZIP: 32218 4 1 tm228848-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-03-09 0 0001860543 Cadre Holdings, Inc. CDRE 0000935577 KANDERS WARREN B C/O CADRE HOLDINGS, INC. 13386 INTERNATIONAL PKWY JACKSONVILLE FL 32218 1 1 1 0 CEO AND CHAIRMAN Common Stock, par value $0.0001 per share ("Common Stock") 2022-03-09 4 A 0 31250 0 A Common Stock 31250 31250 D Stock Option (right to purchase) 23.45 2022-03-09 4 A 0 113636 0 A 2032-03-09 Common Stock 113636 113636 D Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 31,250 restricted shares of Common Stock. 10,416 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2023 and 10,417 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 37,878 shares of the Issuer's Common Stock will vest and become exercisable on March 9, 2023 and options to purchase 37,879 shares of the Issuer's Common Stock will vest and become exercisable on each of March 9, 2024 and March 9, 2025. /s/ Warren B. Kanders 2022-03-11